This page includes the latest FDA filings for Lexicon Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | LXRX | DUNS 838179638 |
Device Company | Device | Date |
---|---|---|
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2024-01-30 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2023-11-08 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2023-06-08 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2022-10-27 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2022-10-27 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2021-02-17 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2021-02-11 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2019-12-20 |
Lexicon Pharmaceuticals, Inc. | Prescription Medication | 2017-06-24 |
Lexicon Pharmaceuticals, Inc. | Xermelo | 2017-03-01 |
NCAGE Code | 1U7Y1 | LEXICON PHARMACEUTICALS, INC. |
CAGE Code | 1U7Y1 | LEXICON PHARMACEUTICALS, INC. |
S.A.M. Registration | 1U7Y1 [838179638] | LEXICON PHARMACEUTICALS, INC. |
SEC | 0001062822 | LEXICON PHARMACEUTICALS, INC. of DELAWARE |